Literature DB >> 1977617

Expression of the cholecystokinin gene in a human (small-cell) lung carcinoma cell-line.

T Geijer1, R Folkesson, J F Rehfeld, H J Monstein.   

Abstract

Expression of the cholecystokinin (CCK), gastrin and enkephalin A genes were studied by Northern blot analysis and a library of sequence-specific radioimmunoassays in human cell lines. The human small-cell lung carcinoma line (SCLC) U-1690 expressed moderate levels of CCK mRNA as compared to the human neuroepithelioma cell line SK-N-MC. Neither gastrin nor (pro)enkephalin A mRNAs were detectable in the U-1690 cell line. In contrast, the SCLC-line H-69 expressed Enk A but no CCK mRNA. The radioimmunoassays showed that the CCK mRNA transcript in the SCLC line U-1690 also is translated, and that preproCCK is processed into bioactive, carboxyamidated CCK peptides. Thus, the human small cell carcinoma cell line U-1690 is a useful model for studies of cell-specific CCK gene expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977617     DOI: 10.1016/0014-5793(90)81227-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Cardiomyocyte expression and cell-specific processing of procholecystokinin.

Authors:  Jens P Goetze; Anders H Johnsen; Caroline Kistorp; Finn Gustafsson; Camilla B Johnbeck; Jens F Rehfeld
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

2.  The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6.

Authors:  Jens F Rehfeld; Jens R Bundgaard; Jens Hannibal; Xiaorong Zhu; Christina Norrbom; Donald F Steiner; Lennart Friis-Hansen
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

Review 3.  Exploiting cancer's phenotypic guise against itself: targeting ectopically expressed peptide G-protein coupled receptors for lung cancer therapy.

Authors:  Mahjabin Khan; Tao Huang; Cheng-Yuan Lin; Jiang Wu; Bao-Min Fan; Zhao-Xiang Bian
Journal:  Oncotarget       Date:  2017-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.